New shot tested to cut Kids' migraine days in half

NCT ID NCT04464707

Completed Disease control Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether monthly injections of a drug called fremanezumab could help prevent chronic migraines in children and teenagers aged 6 to 17. Researchers compared the drug to a placebo (inactive shot) in 292 participants to see if it safely reduced the number of migraine days per month. The main goal was to see if the treatment could lower how often these young patients experienced debilitating migraines over a 12-week period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Teva Investigational Site 11179

Ottawa, Ontario, K2G 1W2, Canada
Teva Investigational Site 11180

Ajax, Ontario, L1Z 0M1, Canada
Teva Investigational Site 11181

Montreal, Quebec, H4A 3J1, Canada
Teva Investigational Site 11182

Ottawa, Ontario, K1H 8L1, Canada
Teva Investigational Site 14241

San Antonio, Texas, 78240, United States
Teva Investigational Site 14243

Atlanta, Georgia, 30328, United States
Teva Investigational Site 14244

Jacksonville, Florida, 32256, United States
Teva Investigational Site 14245

Wichita, Kansas, 67206, United States
Teva Investigational Site 14246

Waltham, Massachusetts, 02451, United States
Teva Investigational Site 14248

Raleigh, North Carolina, 27607, United States
Teva Investigational Site 14250

West Palm Beach, Florida, 33407, United States
Teva Investigational Site 14251

Ann Arbor, Michigan, 48104, United States
Teva Investigational Site 14252

Austin, Texas, 78731, United States
Teva Investigational Site 14253

Banning, California, 92220, United States
Teva Investigational Site 14255

West Palm Beach, Florida, 33409, United States
Teva Investigational Site 14256

Bridgeton, Missouri, 63044-2513, United States
Teva Investigational Site 14257

Oklahoma City, Oklahoma, 73112, United States
Teva Investigational Site 14258

Savannah, Georgia, 31406, United States
Teva Investigational Site 14263

Hoffman Estates, Illinois, 60169, United States
Teva Investigational Site 14264

Cincinnati, Ohio, 45229-3039, United States
Teva Investigational Site 14270

Minneapolis, Minnesota, 55402, United States
Teva Investigational Site 14273

Austin, Texas, 78759, United States
Teva Investigational Site 14274

Houston, Texas, 77024, United States
Teva Investigational Site 14275

Oklahoma City, Oklahoma, 73116, United States
Teva Investigational Site 14276

Amherst, New York, 14226, United States
Teva Investigational Site 14277

Tacoma, Washington, 98405, United States
Teva Investigational Site 14281

Little Rock, Arkansas, 72202, United States
Teva Investigational Site 14283

Park Ridge, Illinois, 60068, United States
Teva Investigational Site 14312

Houston, Texas, 77087, United States
Teva Investigational Site 14317

Silver Spring, Maryland, 20910, United States
Teva Investigational Site 14319

Aurora, Colorado, 80045, United States
Teva Investigational Site 14322

Los Angeles, California, 90027, United States
Teva Investigational Site 14323

Norfolk, Virginia, 23510, United States
Teva Investigational Site 14325

Miami, Florida, 33155, United States
Teva Investigational Site 14327

Louisville, Kentucky, 40202, United States
Teva Investigational Site 14360

Covington, Louisiana, 70433, United States
Teva Investigational Site 14361

Sacramento, California, 95815, United States
Teva Investigational Site 14363

Tulsa, Oklahoma, 74136, United States
Teva Investigational Site 14364

Philadelphia, Pennsylvania, 19104-4318, United States
Teva Investigational Site 14365

Baltimore, Maryland, 21201, United States
Teva Investigational Site 14366

San Antonio, Texas, 78207, United States
Teva Investigational Site 14367

Dallas, Texas, 75235-7701, United States
Teva Investigational Site 14368

Colorado Springs, Colorado, 80907, United States
Teva Investigational Site 14370

Loma Linda, California, 92354, United States
Teva Investigational Site 14371

New Brunswick, New Jersey, 08901, United States
Teva Investigational Site 14374

Bristol, Tennessee, 37620, United States
Teva Investigational Site 14375

Salt Lake City, Utah, 84109, United States
Teva Investigational Site 14376

Ridgeland, Mississippi, 39157, United States
Teva Investigational Site 14377

Durham, North Carolina, 27710, United States
Teva Investigational Site 30225

Rome, 00166, Italy
Teva Investigational Site 30226

Milan, 20154, Italy
Teva Investigational Site 30227

Pavia, 27100, Italy
Teva Investigational Site 30228

Milan, 20133, Italy
Teva Investigational Site 30230

Florence, 50139, Italy
Teva Investigational Site 30238

Padua, 35128, Italy
Teva Investigational Site 30239

Milan, 20132, Italy
Teva Investigational Site 31265

Valladolid, 47010, Spain
Teva Investigational Site 31266

Elda, 03600, Spain
Teva Investigational Site 31267

Madrid, 28046, Spain
Teva Investigational Site 31268

Madrid, 28007, Spain
Teva Investigational Site 31270

Valencia, 46026, Spain
Teva Investigational Site 31271

Barcelona, 08035, Spain
Teva Investigational Site 32724

Essen, 452133, Germany
Teva Investigational Site 32725

Dresden, 01307, Germany
Teva Investigational Site 32726

Leipzig, 04177, Germany
Teva Investigational Site 32728

Bad Homburg, 61348, Germany
Teva Investigational Site 32729

Berlin, 13353, Germany
Teva Investigational Site 38135

Nijmegen, 6532 SZ, Netherlands
Teva Investigational Site 38136

Rotterdam, 3015 GD, Netherlands
Teva Investigational Site 38138

Doetinchem, 7009 BL, Netherlands
Teva Investigational Site 40049

Kuopio, 70210, Finland
Teva Investigational Site 40052

Tampere, 33521, Finland
Teva Investigational Site 40053

Helsinki, 00380, Finland
Teva Investigational Site 40054

Oulu, 90100, Finland
Teva Investigational Site 53437

Kielce, 25-316, Poland
Teva Investigational Site 53439

Poznan, 60-355, Poland
Teva Investigational Site 53440

Lublin, 20-582, Poland
Teva Investigational Site 53441

Gdansk, 80-389, Poland
Teva Investigational Site 53442

Szczecin, 70-111, Poland
Teva Investigational Site 53443

Krakow, 30-363, Poland
Teva Investigational Site 53451

Poznan, 61-731, Poland
Teva Investigational Site 53452

Krakow, 30-539, Poland
Teva Investigational Site 80164

Safed, 1311001, Israel
Teva Investigational Site 80165

Tel Aviv, 6423906, Israel
Teva Investigational Site 80166

Haifa, 3339419, Israel
Teva Investigational Site 80167

Ramat Gan, 5265601, Israel
Teva Investigational Site 80168

Holon, 58100, Israel
Teva Investigational Site 80169

Jerusalem, 9124001, Israel
Teva Investigational Site 80170

Be’er Ya‘aqov, 7033001, Israel

Conditions

Explore the condition pages connected to this study.

MIGRAINE